Please login to the form below

Not currently logged in
Email:
Password:

MIT chief financial officer joins Moderna Therapeutics

Israel Ruiz to serve as audit committee chair on its board of directors

US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee chair.

Ruiz is currently executive vice president, treasurer and chief financial officer at Massachusetts Institute of Technology (MIT), where he is responsible for leading all of the institute's administrative and financial operations.

Before taking on his current role in 2011, Ruiz held a number of leadership positions at MIT, including vice president of finance, and lead the institute's digital learning technologies drive.

Ruiz also serves as audit committee chair on Fortive's board of directors, an industrial growth technology specialist.

Dr Noubar Afeyan, co-founder and chairman of Moderna Therapeutics, said: “We are delighted to welcome Israel to Moderna's board of directors.

“His progressive leadership at MIT has helped ensure the continued, unparalleled contributions of the institute on a regional, national and global scale, through education, innovation and entrepreneurship.

“We look forward to leveraging Israel's insights as Moderna evolves into a leading, clinical stage biotechnology company by harnessing the promise of messenger RNA science to improve lives.”

1st March 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics